Discrepancies in the management of acquired cold contact urticaria: Results of a French-speaking urticaria experts questionnaire survey

Aurélie Du-Thanh, MD, PhD; Angèle Soria, MD, PhD; Emmanuelle Amsler, MD; Antoine Badaoui, MD; Marie-Sylvie Doutre, MD, PhD; Germaine Gabison, MD; Claire Bernier, MD; Delphine Staumont-Sallé, MD, PhD; Florence Hacard, MD; Florence Castelain, MD; Anne-Sophie Darrigade, MD; Gilbert Patrice ML Tapsoba, MD; Marie-Elodie Sarre, MD; Pascale Mathelier-Fusade, MD; Juliette Delaunay, MD; Pauline Pralong, MD; Annick Barbaud, MD, PhD; Frédéric Dezoteux, MD; Catherine Trémeau-Martinage, MD; Zhary Bachtarzi, MD; Frédéric Augey, MD

World Allergy Organization Journal (Sep 2022)

Discrepancies in the management of acquired cold contact urticaria: Results of a French-speaking urticaria experts questionnaire survey

Aurélie Du-Thanh, MD, PhD,
Angèle Soria, MD, PhD,
Emmanuelle Amsler, MD,
Antoine Badaoui, MD,
Marie-Sylvie Doutre, MD, PhD,
Germaine Gabison, MD,
Claire Bernier, MD,
Delphine Staumont-Sallé, MD, PhD,
Florence Hacard, MD,
Florence Castelain, MD,
Anne-Sophie Darrigade, MD,
Gilbert Patrice ML Tapsoba, MD,
Marie-Elodie Sarre, MD,
Pascale Mathelier-Fusade, MD,
Juliette Delaunay, MD,
Pauline Pralong, MD,
Annick Barbaud, MD, PhD,
Frédéric Dezoteux, MD,
Catherine Trémeau-Martinage, MD,
Zhary Bachtarzi, MD,
Frédéric Augey, MD

Affiliations

Aurélie Du-Thanh, MD, PhD: Dermatology, University of Montpellier, Montpellier, France; Corresponding author. Dermatology, University of Montpellier, Montpellier, France.
Angèle Soria, MD, PhD: Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé, Publique, AP-HP Sorbonne Université, Hôpital Tenon, Département de dermatologie et allergologie, F75020, Paris, France
Emmanuelle Amsler, MD: Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé, Publique, AP-HP Sorbonne Université, Hôpital Tenon, Département de dermatologie et allergologie, F75020, Paris, France
Antoine Badaoui, MD: Cabinet de Dermatologie et Allergologie, 14 rue de Chateaudun, 75009 Paris, France
Marie-Sylvie Doutre, MD, PhD: Dermatology, University Hospital of Bordeaux, Bordeaux, France
Germaine Gabison, MD: Dermatology, APHP, Paris, France
Claire Bernier, MD: Dermatology, University Hospital of Nantes, Nantes, France
Delphine Staumont-Sallé, MD, PhD: Dermatology, University Hospital of Lille, Lille, France
Florence Hacard, MD: Dermatology, University Hospital of Lyon-Sud, Pierre-Benite, France
Florence Castelain, MD: Dermatology, University Hospital of Besançon, Besançon, France
Anne-Sophie Darrigade, MD: Dermatology, University Hospital of Bordeaux, Bordeaux, France
Gilbert Patrice ML Tapsoba, MD: Dermatology, University Hospital, Yalgado Ouedraogo, Ouagadougou, Burkina Faso
Marie-Elodie Sarre, MD: Dermatology, University Hospital of Nantes, Nantes, France
Pascale Mathelier-Fusade, MD: Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé, Publique, AP-HP Sorbonne Université, Hôpital Tenon, Département de dermatologie et allergologie, F75020, Paris, France
Juliette Delaunay, MD: Dermatology, University Hospital of Angers, Angers, France
Pauline Pralong, MD: Dermatology, University Hospital of Grenoble, Grenoble, France
Annick Barbaud, MD, PhD: Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé, Publique, AP-HP Sorbonne Université, Hôpital Tenon, Département de dermatologie et allergologie, F75020, Paris, France
Frédéric Dezoteux, MD: Dermatology, University Hospital of Lille, Lille, France
Catherine Trémeau-Martinage, MD: Cabinet de Dermatologie, 4 rue de la Placette, Portet sur Garonne, France
Zhary Bachtarzi, MD: Cabinet d’Allergologie, Cité du 5 juillet 1962, Constantine, Algeria
Frédéric Augey, MD: Dermatology, University Hospital of Lyon-Sud, Pierre-Benite, France

Journal volume & issue: Vol. 15, no. 9
p. 100688

Abstract

Read online

Acquired cold contact urticaria (ACU) is a putatively serious condition, because of the risk of anaphylactic shock whenever patients are massively exposed to cold atmosphere/water, raising the question of the prescription of an “emergency kit” with oral antihistamines and epinephrine auto-injector. We performed an online survey to evaluate how French-speaking urticaria experts manage ACU. According to the 2016 consensus recommendations on chronic inducible urticarias, all the participants perform at least 1 of the available provocation tests and 84.2%, 77.8%, and 88.9% prescribe on-label use of second generation anti-H1 antihistamines (2GAH1) as a first line treatment, updosed 2GAH1 as a second line treatment, and omalizumab as a third line treatment, respectively. Interestingly, 44.4% of the practitioners always prescribe a continuous background treatment, versus 11.1% prescribing only on-demand therapy. Also, 11.7% of participants always prescribe an epinephrine auto-injector, 70.6% sometimes do, and 17.6% never do. Finally, 89.5% authorize swimming under strict conditions but 36.8% and 68.4% contra-indicate other water sports and occupational cold exposure, respectively.

Published in World Allergy Organization Journal

ISSN: 1939-4551 (Online)
Publisher: Elsevier
Country of publisher: Netherlands
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
Website: https://www.sciencedirect.com/journal/world-allergy-organization-journal

About the journal

Abstract

Keywords